@jepcastel

Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database

, , , and . British Journal of Clinical Pharmacology, 72 (6): 905--908 (November 2011)
DOI: 10.1111/j.1365-2125.2011.04037.x

Links and resources

Tags